- You are viewing a Navigating Care library resource.
- Go to Library
Treatment of Localized Transitional Cell Cancer of the Renal Pelvis and Ureter
Treatment of localized transitional cell cancer of the renal pelvis and ureter may include:
- surgery (nephroureterectomy or segmental resection of ureter)
- a clinical trial of fulguration
- a clinical trial of laser surgery
- a clinical trial of segmental resection of the renal pelvis
- a clinical trial of regional chemotherapy or regional immunotherapy
To learn more about these treatments, see the Treatment Option Overview.
Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.
Learn more:
- General Information About Transitional Cell Cancer of the Renal Pelvis and Ureter
- Stages of Transitional Cell Cancer of the Renal Pelvis and Ureter
- Treatment Option Overview for Transitional Cell Cancer of the Renal Pelvis and Ureter
- Treatment of Localized Transitional Cell Cancer of the Renal Pelvis and Ureter
- Treatment of Regional Transitional Cell Cancer of the Renal Pelvis and Ureter
- Treatment of Metastatic or Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter
- To Learn More About Transitional Cell Cancer of the Renal Pelvis and Ureter
Related Articles
- General Information About Transitional Cell Cancer of the Renal Pelvis and Ureter
- Stages of Transitional Cell Cancer of the Renal Pelvis and Ureter
- Treatment Option Overview for Transitional Cell Cancer of the Renal Pelvis and Ureter
- Treatment of Localized Transitional Cell Cancer of the Renal Pelvis and Ureter
- Treatment of Regional Transitional Cell Cancer of the Renal Pelvis and Ureter
- Treatment of Metastatic or Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter
- To Learn More About Transitional Cell Cancer of the Renal Pelvis and Ureter